Position history for BlackRock, Inc.'s holdings in ENLIVEN THERAPEUTICS INC
BlackRock, Inc. holds 3.7M shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $144.4M as of 2026-Q1. The position was increased (+2.0% shares). ELVN represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$144.4M
Current Shares
3.7M
Total Value Change
+$77.7M
Total Shares Change
+719,579
Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc
Increased |
| 3.7M |
+2.0% |
| $144.4M |
| 0.0% |
| $28.75 |
31 |
| 2025-Q4 | Increased | 3.6M | +2.7% | $55.6M | 0.0% | $15.55 | 30 |
| 2025-Q3 | Increased | 3.5M | +18.6% | $72M | 0.0% | $20.30 | 35 |
| 2025-Q2 | Decreased | 3M | -1.0% | $59.5M | 0.0% | $20.68 | 0 |
| 2025-Q1 | Increased | 3M | +1.1% | $59M | 0.0% | $21.07 | 30 |
| 2024-Q4 | New | 3M | - | $66.7M | 0.0% | $22.39 | 41 |